Nooruddin, Z., Gilmore, C., Moore, A., Burton, E. M., Franklin, K., Jones, X., Reveles, K. R., Cotarla, I., Simmons, D., Frei, C. R. (2026). Cancer-related overall survival for patients on durvalumab for stage III unresectable non–small cell lung cancer with PD-L1 positive and negative tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8026